|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 43/04 | |
| A61K 31/7052 | |||
| A61P 27/02 | |||
| A61K 9/00 |
| (11) | Number of the document | 2313103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09795262.6 |
| Date of filing the European patent application | 2009-07-10 | |
| (97) | Date of publication of the European application | 2011-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/050311 |
| Date | 2009-07-10 |
| (87) | Number | WO 2010/006306 |
| Date | 2010-01-14 |
| (30) | Number | Date | Country code |
| 79772 P | 2008-07-10 | US |
| (72) |
BRUBAKER, Kurt, E., US
BRAZZELL, Romulus, Kimbro, US
HAQUE, Reza, US
ICE, John, C., US
BOYER, Jose, L., US
BOYD, Joseph, B., US
|
| (73) |
Inspire Pharmaceuticals, Inc.,
8081 Arco Corporate Drive, Suite 400, Raleigh, NC 27617,
US
|
| (54) | METHOD OF TREATING BLEPHARITIS |
| METHOD OF TREATING BLEPHARITIS |